n,n-dimethylarginine has been researched along with Schizophrenia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, D; Haen, E; Schlossmann, J | 1 |
| Ak, M; Celik, C; Doruk, A; Erdem, M; Garip, B; Karaahmetoğlu, B; Yükselir, C; Zincir, S; Zincir, SB | 1 |
| Fink-Jensen, A; Jorgensen, A; Jorgensen, MB; Knorr, U; Lykkesfeldt, J; Olsen, NV; Poulsen, HE; Soendergaard, MG; Staalsø, JM | 1 |
| Akiyama, K; Fujii, K; Homma, H; Katane, M; Miyamoto, T; Nonaka-Hashida, S; Ozeki, Y; Saitoh, Y; Sekine, M; Shimoda, K; Tsunoda, M | 1 |
| Dursun, SM; Hallak, JE; Kandratavicius, L; Machado-de-Sousa, JP; Maia-de-Oliveira, JP; Nunes, EA | 1 |
| Chen, HB; Hu, MR; Wei, B; Xiong, JW; Yan, K; Yang, YJ; Yu, B; Zhan, JQ; Zhao, Y | 1 |
| Akgul, EO; Balikci, A; Cayci, T; Celik, C; Ozdemir, B; Uzun, O; Yaman, H; Zincir, S | 1 |
1 review(s) available for n,n-dimethylarginine and Schizophrenia
| Article | Year |
|---|---|
Nitric Oxide's Involvement in the Spectrum of Psychotic Disorders.
Topics: Antipsychotic Agents; Arginine; Brain; Clinical Trials as Topic; Humans; Nitric Oxide; Nitric Oxide Synthase; Phosphodiesterase 5 Inhibitors; Psychotic Disorders; Schizophrenia; Sildenafil Citrate | 2016 |
6 other study(ies) available for n,n-dimethylarginine and Schizophrenia
| Article | Year |
|---|---|
Asymmetric dimethylarginine in psychiatric disorders.
Topics: Arginine; Bipolar Disorder; Female; Humans; Male; Psychotic Disorders; Schizophrenia | 2021 |
Asymmetric dimethylarginine (ADMA) and treatment response relationship in male patients with first-episode schizophrenia: a controlled study.
Topics: Adult; Antipsychotic Agents; Arginine; Humans; Male; Middle Aged; Nitric Oxide; Schizophrenia; Treatment Outcome; Young Adult | 2014 |
Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control study.
Topics: Adult; Antipsychotic Agents; Arginine; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Male; Oxidative Stress; Schizophrenia | 2015 |
Plasma concentrations of three methylated arginines, endogenous nitric oxide synthase inhibitors, in schizophrenic patients undergoing antipsychotic drug treatment.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Arginine; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Schizophrenia; Treatment Outcome; Young Adult | 2016 |
Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia.
Topics: Adult; Arginine; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Female; Humans; Male; Neuropsychological Tests; Schizophrenia; Young Adult | 2016 |
Plasma asymmetric dimethylarginine (ADMA) concentrations in patients with first and multiple episode schizophrenia.
Topics: Adult; Arginine; Chromatography, High Pressure Liquid; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Statistics, Nonparametric; Young Adult | 2011 |